The Randomized Clinical Trial of Safety and Efficacy of Oral Tramadol in Patients Undergoing Colonoscopy

AuthorMehdi Zobeirien
AuthorTeimour Kamarien
AuthorMansour Rezaeien
AuthorMohammadHossein Farzaeien
OrcidMehdi Zobeiri [0000-0003-4206-0282]en
OrcidMohammadHossein Farzaei [0000-0001-7081-6521]en
Issued Date2021-12-31en
AbstractBackground and Study Aims: Colonoscopy is a wide-spreading procedure with pain as a habitual challenge for the therapeutic team. The aim of this study is to evaluate safety and efficacy of oral tramadol in patients undergoing colonoscopy. Patients and Methods: This randomized controlled trial was performed in 124 consecutive patients who completed total colonoscopy, which is randomly divided into two groups, receiving either 100 mg single dose oral tramadol or placebo. Pain intensity during colonoscopy is evaluated by numerical rating scale (NRS) criteria in four levels: no pain, mild, moderate, and severe pain. This study was registered in www.IRCT.ir, number: IRCT2015010820610N1. Results: Two groups were matched in age, sex, and colonoscopy indication. The pain intensity in patients receiving tramadol was significantly lower than that in patients receiving placebo (Pen
DOIhttps://doi.org/10.4103/jrptps.JRPTPS_9_21en
KeywordClinicalen
Keywordcolonoscopyen
Keywordpainen
Keywordsafetyen
Keywordtramadolen
PublisherBrieflandsen
TitleThe Randomized Clinical Trial of Safety and Efficacy of Oral Tramadol in Patients Undergoing Colonoscopyen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
the_randomized_clinical_trial_of_safety_and.14-1-1.pdf
Size:
254.96 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF